Results 231 to 240 of about 80,926 (308)

Thrombotic Thrombocytopenic Purpura Masked by Severe Preeclampsia: A Case Report. [PDF]

Cureus
Alabdulmohsen DM, Alhashim JN.
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

Expectant Management of Severe Preeclampsia in Advanced Maternal Age With Multiple Risk Factors: A Case Report. [PDF]

Cureus
Zakour Khadari M, Zainal H, Daud NAA, Sha'aban A.   +3 more
europepmc   +1 more source

An evaluation of antenatal corticosteroid use and timing in a large US birth cohort 2017–2021

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction There is a lack of published data on the contemporary use and timing of antenatal corticosteroids in the United States. Our primary objective was to address this gap using clinical data from a large US birth cohort. Our secondary objective was to identify factors associated with optimally timed steroids in births <34 weeks ...
Vivienne Souter, C. Andrew Combs, Ian Painter, Kristin Sitcov, Lisa Foglia, Sarah M. Edwards, Asma Khalil, Andreas Hoehn   +7 more
wiley   +1 more source

Conservative management of giant retroperitoneal hematoma after cesarean section in severe preeclampsia: a rare case report. [PDF]

BMC Pregnancy Childbirth
Yu J, Ke M, Wang G.
europepmc   +1 more source

Postpartum readmission for hypertension: Validating a predictive model with incorporation of neighborhood‐level social determinants of health

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Objective To refine a pre‐existing predictive model (“the original calculator”) for postpartum readmission for hypertensive disorders of pregnancy (HDP), and to assess whether model performance is further enhanced by adding neighborhood‐level social determinants of health (SDOH).
Celeste A. Green, Brooklynn Earls, Michael Jochum, J. Eric Jelovsek, Kartik Venkatesh, April D. Adams, Dominique Williams   +6 more
wiley   +1 more source

Maternal morbidity in postpartum severe preeclampsia by obstetric delivery volume. [PDF]

Am J Obstet Gynecol MFM
Santoli CMA, Unnithan S, Truong T, Dotters-Katz SK, Federspiel JJ.   +4 more
europepmc   +1 more source

First‐trimester preexisting diabetes screening in Medicaid beneficiaries

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Patients with public insurance have higher rates of pregestational diabetes mellitus (DM) and are less likely to receive preconception care than those with private insurance. First trimester DM screening rates among high‐risk publicly insured pregnant individuals in the United States are unknown.
Zeinab Kassem, Sebastian Z. Ramos, Benjamin Koethe, Mohak Mhatre   +3 more
wiley   +1 more source

Soluble fms‐like tyrosine kinase‐1 and placental growth factor as predictors of adverse maternal events in women with a confirmed diagnosis of preeclampsia

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Objective Soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth factor (PlGF) have been identified as predictors for preeclampsia and time to birth in women with suspected preeclampsia. This study aims to investigate these markers as predictors of adverse maternal events in women with confirmed preeclampsia.
Niclas Carlberg, Camilla Hesse, Sven‐Egron Thörn, Tor Damén, Henrik Imberg, Nicole Wallin, Malin Andersson, Verena Sengpiel, Lina Bergman   +8 more
wiley   +1 more source

Multi-omics-based mapping of decidualization resistance in patients with a history of severe preeclampsia. [PDF]

Nat Med
Muñoz-Blat I, Pérez-Moraga R, Castillo-Marco N, Cordero T, Ochando A, Ortega-Sanchís S, Parras-Moltó M, Monfort-Ortiz R, Satorres-Perez E, Novillo B, Perales A, Gormley M, Granados-Aparici S, Noguera R, Roson B, Fisher SJ, Simón C, Garrido-Gómez T.   +17 more
europepmc   +1 more source